{
    "eu_accel_assess_g": "attribute not available on release",
    "eu_od_date": "__SCRAPER_NOT_FOUND__",
    "assess_time_days_total": -1,
    "eu_od_pnumber": "__SCRAPER_NOT_FOUND__",
    "active_substance": [
        "Peginterferon alfa-2b",
        "0001-01-01"
    ],
    "assess_time_days_active": -1,
    "eu_od_sponsor": "__SCRAPER_NOT_FOUND__",
    "eu_aut_status": "WITHDRAWN",
    "eu_od_comp_date": "__SCRAPER_NOT_FOUND__",
    "eu_brand_name_current": [
        {
            "value": "PegIntron",
            "date": "22/12/2022"
        }
    ],
    "assess_time_days_cstop": -1,
    "eu_prime_initial": {
        "value": "attribute not available on release",
        "date": "0001-01-01"
    },
    "ema_corapp": "prof. a. hildebrandt",
    "eu_indication_initial": {
        "value": "[pharmaceutical form and contents; pharmacotherapeutic group] the pharmaceutical form is: powder and solvent for solution for injection. the powder is contained in a 2 ml vial and the solvent is presented in a 2 ml ampoule.\n\n therapeutic indications interferons modify the response of the body's immune system to help fight infections and severe diseases. pegintron, which contains an interferon, is used alone, in case of intolerance or contraindication to \n ribavirin to treat chronic hepatitis c, a viral infection of the liver.\n\n the optimal treatment for chronic hepatitis c is the combination of interferon alfa-2b with ribavirin.\n",
        "date": "0001-01-01"
    },
    "ec_decision_time_days": -1,
    "eu_od_con": "__SCRAPER_NOT_FOUND__",
    "eu_od_initial": {
        "value": "__SCRAPER_NOT_FOUND__",
        "date": "0001-01-01"
    },
    "ema_reexamination": "False",
    "eu_aut_date": "2000-05-25",
    "ema_omar_condition": "__SCRAPER_NOT_FOUND__",
    "atc_code": "L03AB10",
    "eu_orphan_con_current": [
        {
            "value": "__SCRAPER_NOT_FOUND__",
            "date": "22/12/2022"
        }
    ],
    "eu_aut_type_initial": {
        "value": "attribute not available on release",
        "date": "0001-01-01"
    },
    "chmp_opinion_date": "2000-02-17",
    "eu_referral": "False",
    "eu_procedures_todo": [
        {
            "eu_referral": false,
            "eu_suspension": false
        }
    ],
    "eu_aut_type_current": [
        {
            "value": "standard",
            "date": "22/12/2022"
        }
    ],
    "ema_rapp": "dr p. nilsson",
    "eu_pnumber": "EU/1/00/131",
    "eu_brand_name_initial": {
        "value": "PegIntron",
        "date": "0001-01-01"
    },
    "eu_suspension": "False",
    "orphan_status": "h",
    "eu_legal_basis": [
        "__SCRAPER_NOT_FOUND__"
    ],
    "ema_number": "EMEA/H/C/280",
    "aut_url": "404_url_not_found",
    "ema_number_id": "280",
    "omar_url": "404_url_not_found",
    "smpc_url": "404_url_not_found",
    "ema_number_certainty": "1.0",
    "epar_url": "404_url_not_found",
    "ema_number_check": [
        true,
        "22/12/2022"
    ],
    "odwar_url": "404_url_not_found",
    "eu_mah_current": [
        {
            "value": "Merck Sharp &amp; Dohme B.V.",
            "date": "22/12/2022"
        }
    ],
    "eu_od_number": "__SCRAPER_NOT_FOUND__",
    "eu_atmp": "attribute not available on release",
    "eu_mah_initial": {
        "value": "SP Europe",
        "date": "0001-01-01"
    },
    "eu_nas": "attribute not available on release",
    "ema_od_number": "__SCRAPER_NOT_FOUND__",
    "ema_procedure_start_initial": "1999-03-26",
    "eu_med_type": [
        "small molecule",
        "0001-01-01"
    ]
}